Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Weinberg

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Annals of Neurology|April 29, 2009
Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trialAllan H Ropper, Kenneth C Gorson, Clifton L Gooch, et al.
Monthly Notices of the Royal Astronomical Society|June 10, 2016
Modelling galaxy clustering: halo occupation distribution versus subhalo matchingHong Guo, Zheng Zheng, Peter S Behroozi, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2005
Design and syntheses of melanocortin subtype-4 receptor agonists. Part 2: discovery of the dihydropyridazinone motifFeroze Ujjainwalla, Daniel Warner, Christine Snedden, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGFRudolf Kirchmair, Anne B Tietz, Eleftheria Panagiotou, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Combinatorial synthesis of 3-(amidoalkyl) and 3-(aminoalkyl)-2-arylindole derivatives: discovery of potent ligands for a variety of G-protein coupled receptorsChristopher A Willoughby, Steven M Hutchins, Keith G Rosauer, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Design and syntheses of melanocortin subtype-4 receptor agonists: evolution of the pyridazinone archetypeFeroze Ujjainwalla, Daniel Warner, Thomas F Walsh, et al.
Peptides|July 5, 2005
Structure-activity relationship of linear tetrapeptides Tic-DPhe-Arg-Trp-NH2 at the human melanocortin-4 receptor and effects on feeding behaviors in ratZhixiong Ye, Tanya MacNeil, David H Weinberg, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2008
Synthesis and SAR of potent and orally bioavailable tert-butylpyrrolidine archetype derived melanocortin subtype-4 receptor modulatorsLiangqin Guo, Zhixiong Ye, Feroze Ujjainwalla, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonistsBrenda L Palucki, Min K Park, Ravi P Nargund, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2007
Melanocortin subtype 4 receptor agonists: structure-activity relationships about the 4-alkyl piperidine coreIyassu K Sebhat, Yingjie Lai, Khaled Barakat, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Annals of Neurology|April 29, 2009
Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trialAllan H Ropper, Kenneth C Gorson, Clifton L Gooch, et al.
Monthly Notices of the Royal Astronomical Society|June 10, 2016
Modelling galaxy clustering: halo occupation distribution versus subhalo matchingHong Guo, Zheng Zheng, Peter S Behroozi, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2005
Design and syntheses of melanocortin subtype-4 receptor agonists. Part 2: discovery of the dihydropyridazinone motifFeroze Ujjainwalla, Daniel Warner, Christine Snedden, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGFRudolf Kirchmair, Anne B Tietz, Eleftheria Panagiotou, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Combinatorial synthesis of 3-(amidoalkyl) and 3-(aminoalkyl)-2-arylindole derivatives: discovery of potent ligands for a variety of G-protein coupled receptorsChristopher A Willoughby, Steven M Hutchins, Keith G Rosauer, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Design and syntheses of melanocortin subtype-4 receptor agonists: evolution of the pyridazinone archetypeFeroze Ujjainwalla, Daniel Warner, Thomas F Walsh, et al.
Peptides|July 5, 2005
Structure-activity relationship of linear tetrapeptides Tic-DPhe-Arg-Trp-NH2 at the human melanocortin-4 receptor and effects on feeding behaviors in ratZhixiong Ye, Tanya MacNeil, David H Weinberg, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2008
Synthesis and SAR of potent and orally bioavailable tert-butylpyrrolidine archetype derived melanocortin subtype-4 receptor modulatorsLiangqin Guo, Zhixiong Ye, Feroze Ujjainwalla, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonistsBrenda L Palucki, Min K Park, Ravi P Nargund, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2007
Melanocortin subtype 4 receptor agonists: structure-activity relationships about the 4-alkyl piperidine coreIyassu K Sebhat, Yingjie Lai, Khaled Barakat, et al.
Pageof 4